Effects of targeting magnetic drug nanoparticles on human cholangiocarcinoma xenografts in nude mice. 2007

Tao Tang, and Jian-Wei Zheng, and Bo Chen, and Hong Li, and Xi Li, and Ke-Ying Xue, and Xing Ai, and Sheng-Quan Zou
Department of General Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. tangtao78521@163.com

BACKGROUND Targeting is a new therapeutic tool for malignant tumor as a result of combining nanotechnology with chemotherapeutics. The aim of our study was to investigate the effects of magnetic nanoparticles enveloping a chemotherapeutic drug on human cholangiocarcinoma xenografts in nude mice. METHODS The human cholangiocarcinoma xenograft model was established in nude mice with the QBC939 cell line. The nude mice were randomly assigned to 7 groups. 0.9% saline or magnetic nanoparticles, including high (group 2), medium (group 4) and low (group 5) dosages, were given to nude mice through the tail vein 20 days after the QBC939 cell line was implanted. Calculations were made 35 days after treatment in order to compare the volumes, inhibition ratios and growth curves of the tumors in each group. Mice in each group were sacrificed randomly to collect tumor tissues and other organs for electron microscopy and pathological examination. RESULTS The high and medium dosage groups were significantly different from the control group (P<0.05). The tumor inhibition ratios for the high, medium and low dosage groups were 39.6%, 14.6% and 7.9%, respectively. The tumor growth curve of groups 5, 4, and 2 changed slowly in turn. The high and medium groups showed cell apoptosis under an electron microscope. CONCLUSIONS Magnetic nanoparticles can inhibit the growth of human cholangiocarcinoma xenografts in nude mice.

UI MeSH Term Description Entries
D008280 Magnetics The study of MAGNETIC PHENOMENA. Magnetic
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001650 Bile Duct Neoplasms Tumors or cancer of the BILE DUCTS. Bile Duct Cancer,Cancer of Bile Duct,Cancer of the Bile Duct,Neoplasms, Bile Duct,Bile Duct Cancers,Bile Duct Neoplasm,Cancer, Bile Duct,Cancers, Bile Duct,Neoplasm, Bile Duct
D001653 Bile Ducts, Intrahepatic Passages within the liver for the conveyance of bile. Includes right and left hepatic ducts even though these may join outside the liver to form the common hepatic duct. Bile Duct, Intrahepatic,Duct, Intrahepatic Bile,Ducts, Intrahepatic Bile,Intrahepatic Bile Duct,Intrahepatic Bile Ducts
D014183 Transplantation, Heterologous Transplantation between animals of different species. Xenotransplantation,Heterograft Transplantation,Heterografting,Heterologous Transplantation,Xenograft Transplantation,Xenografting,Transplantation, Heterograft,Transplantation, Xenograft

Related Publications

Tao Tang, and Jian-Wei Zheng, and Bo Chen, and Hong Li, and Xi Li, and Ke-Ying Xue, and Xing Ai, and Sheng-Quan Zou
January 2013, OncoTargets and therapy,
Tao Tang, and Jian-Wei Zheng, and Bo Chen, and Hong Li, and Xi Li, and Ke-Ying Xue, and Xing Ai, and Sheng-Quan Zou
August 2007, Hepatobiliary & pancreatic diseases international : HBPD INT,
Tao Tang, and Jian-Wei Zheng, and Bo Chen, and Hong Li, and Xi Li, and Ke-Ying Xue, and Xing Ai, and Sheng-Quan Zou
January 1987, Ciba Foundation symposium,
Tao Tang, and Jian-Wei Zheng, and Bo Chen, and Hong Li, and Xi Li, and Ke-Ying Xue, and Xing Ai, and Sheng-Quan Zou
April 2009, World journal of gastroenterology,
Tao Tang, and Jian-Wei Zheng, and Bo Chen, and Hong Li, and Xi Li, and Ke-Ying Xue, and Xing Ai, and Sheng-Quan Zou
January 1998, European journal of gynaecological oncology,
Tao Tang, and Jian-Wei Zheng, and Bo Chen, and Hong Li, and Xi Li, and Ke-Ying Xue, and Xing Ai, and Sheng-Quan Zou
February 2002, Chinese medical journal,
Tao Tang, and Jian-Wei Zheng, and Bo Chen, and Hong Li, and Xi Li, and Ke-Ying Xue, and Xing Ai, and Sheng-Quan Zou
August 1988, Cancer research,
Tao Tang, and Jian-Wei Zheng, and Bo Chen, and Hong Li, and Xi Li, and Ke-Ying Xue, and Xing Ai, and Sheng-Quan Zou
January 1984, Invasion & metastasis,
Tao Tang, and Jian-Wei Zheng, and Bo Chen, and Hong Li, and Xi Li, and Ke-Ying Xue, and Xing Ai, and Sheng-Quan Zou
September 2008, Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition,
Tao Tang, and Jian-Wei Zheng, and Bo Chen, and Hong Li, and Xi Li, and Ke-Ying Xue, and Xing Ai, and Sheng-Quan Zou
January 2010, Oncology research,
Copied contents to your clipboard!